This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Piper Sandler Reaffirms Their Buy Rating on ICU Medical (ICUI)

Tipranks - Tipranks - Tue May 5, 6:52AM CDT

In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on ICU Medical, with a price target of $163.00.

Claim 55% Off TipRanks

Bednar covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, Align Tech, and ICU Medical. According to TipRanks, Bednar has an average return of -5.8% and a 36.76% success rate on recommended stocks.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ICU Medical with a $163.50 average price target.

See the top stocks recommended by analysts >>

Based on ICU Medical’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $540.31 million and a GAAP net loss of $15.73 million. In comparison, last year the company earned a revenue of $629.81 million and had a GAAP net loss of $23.83 million

Read More on ICUI:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).